Kristie Blum

School/Division:

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 14

  1. 1
  2. 2

Article

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

by Jonathon Cohen; Christopher Flowers; Jeffrey Switchenko; Kristie Blum; Krithika Shanmugasundaram; DA Bond; D Villa; K Maddocks; M Churnetski; AS Gerrie; S Goyal; O Calzada; B Kolla; V Bachanova; JN Gerson; SK Barta; BT Hill; Y Sawalha; P Martin; E Maldonado; M Gordon; A Danilov; NS Grover; S Mathews; M Burkart; R Karmali; N Ghosh; S Park; N Epperla; T Badar; J Guo; M Hamadani; TS Fenske; M-K Malecek; BS Kahl

2021

Article

Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey

by Christopher Flowers; Jeffrey Switchenko; Jean Koff; Kristie Blum; RA Harkins; SP Patel; MJ Lee; SM Ansell; NL Bartlett; AF Cashen; C Casulo; JW Friedberg; PB Johnston; BS Kahl; JP Leonard; BK Link; IS Lossos; P Martin; MJ Maurer; N Mehta-Shah; PM Reagan; JR Westin

2022

Article

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial

by Christopher Flowers; Kristie Blum; G Thanarajasingam; JP Leonard; TE Witzig; TM Habermann; NL Bartlett; BN Pitcher; S-H Jung; PJ Atherton; A Tan; PJ Novotny; AC Dueck

2020

Article

Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance)

by Kristie Blum; Mei-Yin Polley; Sin-Ho Jung; Travis J. Dockter; Sarah Anderson; Eric D. Hsi; Nina Wagner-Johnston; Beth Christian; Jim Atkins; Bruce D. Cheson; John P. Leonard; Nancy L. Bartlett

2019

Article

Complex Karyotype in Patients With Mantle Cell Lymphoma Predicts Inferior Survival and Poor Response to Intensive Induction Therapy

by I Brian Greenwell; Ashley D Staton; Michael J Lee; Jeffrey M. Switchenko; Debra Saxe; Joseph J Maly; Kristie Blum; Natalie S Grover; Stephanie Mathews; Max J Gordon; Alexey V Danilov; Narendranath Epperla; Timothy S Fenske; Mehdi Hamadani; Steven I Park; Christopher Flowers; Jonathon B Cohen

2018

Article

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

by Gilles Salles; Stephen J. Schuster; Sven de Vos; Nina D. Wagner-Johnston; Andreas Viardot; Kristie Blum; Christopher Flowers; Wojciech J. Jurczak; Ian W. Flinn; Brad S. Kahl; Peter Martin; Yeonhee Kim; Sanatan Shreay; MAtthias Will; Bess Sorensen; Madlaina Breuleux; Pier Luigi Zinzani; Ajay K. Gopal

2017

Article

Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma

by David A. Bond; Emily Dotson; Farrukh T. Awan; Robert A. Baiocchi; Kristie Blum; Kami Maddocks

2019

Article

The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials

by Frederick Lansigan; Ian Barak; Brandelyn Pitcher; Sin-Ho Jung; Bruce D. Cheson; Myron Czuczman; Peter Martin; Eric Hsi; Heiko Schoder; Scott Smith; Nancy L. Bartlett; John P. Leonard; Kristie Blum

2019

Article

Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R

by Lisa Giulino-Roth; Tara O'Donohue; Zhengming Chen; Nancy L. Bartlett; Ann LaCasce; William Martin-Doyle; Matthew J. Barth; Kimberly Davies; Kristie Blum; Beth Christian; Carla Casulo; Sonali M. Smith; James Godfrey; Amanda Termuhlen; Matthew J. Oberley; Sarah Alexander; Sheila Weitzman; Burton Appel; Benjamin Mizukawa; Melinda Pauly

2017